Pulmonx Corporation (LUNG)
NASDAQ
Delayed Data
Oct 23, 2026, 01:30 PM
Day's Range
1.7952 wk Range
1.13Overview - LUNG - Pulmonx Corporation
Key Statistics
Valuation
Enterprise Value
77.67M
P/E (Trailing)
-1.31
P/E (Forward)
-1.91
PEG Ratio
0.03
Price / Sales (TTM)
0.86
Price / Book
1.97
EV / EBITDA
-1.70
Profitability
Gross Margin
77.96%
Profit Margin
-55.02%
Operating Margin
-39.80%
Return on Assets
-22.10%
Return on Equity
-88.86%
Ownership
Shares Outstanding
42.94M
Float
37.60M
Short % of Shares Outstanding
2.21%
Held by Insiders
4.64%
Held by Institutions
62.81%
Price stats
Beta
0.33
50-Day Avg
2.09
200-Day Avg
1.66
Analyst Consensus
5 analysts
Average price target
$ 3.40Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - LUNG - Pulmonx Corporation
Peers - LUNG - Pulmonx Corporation
Peer Comparison
Compared with companies in Medical Devices listed on NASDAQ.
- LUNGNASDAQPulmonx Corporation74.33MMarket Cap+10.79%52-week change-1.31P/E (Trailing)-55.02%Profit Margin
- GEHCNASDAQGE HealthCare Technologies Inc.32.50BMarket Cap-9.66%52-week change16.43P/E (Trailing)9.33%Profit Margin
- DXCMNASDAQDexCom Inc.32.44BMarket Cap+18.88%52-week change34.14P/E (Trailing)20.11%Profit Margin
- PODDNASDAQInsulet Corporation9.78BMarket Cap-131.64%52-week change26.42P/E (Trailing)12.29%Profit Margin
- TLTLTNASDAQiShares 20+ Year Treasury Bond ETF9.46BMarket Cap-14.37%52-week change—P/E (Trailing)—Profit Margin
- BRKRNASDAQBruker Corp.8.77BMarket Cap+32.91%52-week change74.88P/E (Trailing)-2.03%Profit Margin
- LIVNNASDAQLivaNova PLC4.45BMarket Cap+32.91%52-week change23.93P/E (Trailing)12.81%Profit Margin
Profile Summary - LUNG - Pulmonx Corporation
About
Pulmonx Corporation is a medical technology company focused on minimally invasive treatments for severe emphysema and other obstructive lung diseases. The company’s core offering is the Zephyr Endobronchial Valve, a bronchoscopic implant designed to reduce lung hyperinflation in patients who are not candidates for, or…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
